BackPhio Pharmaceuticals - Warrants (21/12/2021) Overview

Phio Pharmaceuticals - Warrants (21/12/2021) Income Tax

Phio Pharmaceuticals - Warrants (21/12/2021)'s income tax is $0.

Get informed when a big investor buys or sells

+ Follow

Quarterly Income Tax

$0

As of Jun 2026

Annual Income Tax (TTM)

$0
↓ 100.00% YoY

Trailing 12 months ending Jun 2026

Average Income Tax (Comparison Companies)

Loading

Income Tax History

Loading

Income Tax Comparison

Loading

Annual Income Tax Growth Rate (%)

Loading...

Annual Income Tax Growth (Absolute)

Loading...

Phio Pharmaceuticals - Warrants (21/12/2021) (PHIOW) FAQ

The latest income tax for PHIOW is $0 as of June 2026. That compares with $9.3K in the prior-year period — down 100.0% year over year. Investors often review this figure alongside Phio Pharmaceuticals - Warrants (21/12/2021)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PHIOW's income tax moved from $9.3K to $0 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Phio Pharmaceuticals - Warrants (21/12/2021)'s operating scale or balance-sheet position.

A income tax figure of $0 for PHIOW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PHIOW's income tax ($0), review year-over-year change from $9.3K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Phio Pharmaceuticals - Warrants (21/12/2021)'s income tax against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.